We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

134 hedge funds and large institutions have $418M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 60 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 30

59% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 17

9% more capital invested

Capital invested by funds: $385M → $418M (+$33M)

6% more funds holding

Funds holding: 127134 (+7)

Holders
134
Holders Change
+7
Holders Change %
+5.51%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
60
Reduced
30
Closed
17
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$376K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$1.18M
Charles Schwab
52
Charles Schwab
California
$1.13M -$177K -11,259 -14%
Bank of Nova Scotia
53
Bank of Nova Scotia
Ontario, Canada
$945K -$85.8K -5,450 -8%
VOYA Investment Management
54
VOYA Investment Management
Georgia
$842K +$297K +18,837 +55%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$802K -$373K -23,700 -32%
GPC
56
Glacier Peak Capital
Washington
$796K +$460K +29,246 +141%
Thrivent Financial for Lutherans
57
Thrivent Financial for Lutherans
Minnesota
$735K +$191K +12,110 +36%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$652K +$10.2K +646 +2%
QI
59
QS Investors
New York
$641K
Balyasny Asset Management
60
Balyasny Asset Management
Illinois
$632K +$626K +39,731 New
RJFSA
61
Raymond James Financial Services Advisors
Florida
$593K +$128K +8,120 +28%
BG
62
BlackRock Group
United Kingdom
$591K -$6.34K -403 -1%
Bank of America
63
Bank of America
North Carolina
$591K +$343K +21,776 +141%
SM
64
Senvest Management
New York
$587K +$581K +36,919 New
BA
65
BlackRock Advisors
Delaware
$562K -$372K -23,601 -40%
AllianceBernstein
66
AllianceBernstein
Tennessee
$529K -$40.9K -2,600 -7%
PP
67
PDT Partners
New York
$501K +$496K +31,500 New
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
$496K +$490K +31,154 New
CA
69
Commerzbank Aktiengesellschaft
Germany
$495K +$81.3K +5,162 +20%
ProShare Advisors
70
ProShare Advisors
Maryland
$480K +$42.4K +2,691 +10%
Bank of Montreal
71
Bank of Montreal
Ontario, Canada
$480K +$84.2K +5,347 +22%
LCM
72
Landscape Capital Management
New Jersey
$451K +$447K +28,377 New
GCP
73
GSA Capital Partners
United Kingdom
$445K +$440K +27,960 New
Swiss National Bank
74
Swiss National Bank
Switzerland
$423K
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$420K +$368K +23,371 +775%

SGNT Hedge Fund Activity: Q4 2015 in Review

134 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2015, worth a combined $418M — up 8.6% from $385M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SGNT positions and 17 closed out — a net gain of 10 holders — while 60 added to existing stakes and 30 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $10.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.8M sold.

  • 134 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2015, up from 127 in Q3 2015.
  • Funds reported $418M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, up 8.6% quarter-over-quarter.
  • 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 17 closed out, a net change of +10 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2015 was Eagle Asset Management, an estimated $10.1M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was Scopia Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2015.